Literature DB >> 20395419

Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

Michaela Liedtke1, Paul M Ayton, Tim C P Somervaille, Kevin S Smith, Michael L Cleary.   

Abstract

MLL is a common target for chromosomal translocations associated with acute leukemia resulting in its fusion with a large variety of nuclear or cytoplasmic proteins that may activate its oncogenic properties by distinct but poorly understood mechanisms. The MLL-AF6 fusion gene represents the most common leukemogenic fusion of mixed lineage leukemia (MLL) to a cytoplasmic partner protein. Here, we identified a highly conserved Ras association (RA1) domain at the amino-terminus of AF6 as the minimal region sufficient for MLL-AF6 mediated myeloid progenitor immortalization in vitro and short latency leukemogenesis in vivo. Moreover, the ability of RA1 to activate MLL oncogenesis is conserved with its Drosophila ortholog, Canoe. Although the AF6 RA1 domain has previously been defined as an interaction surface for guanosine triphosphate-bound Ras, single amino acid substitutions known to abolish the AF6-Ras interaction did not abrogate MLL-AF6-mediated oncogenesis. Furthermore, fusion of MLL to heterologous RA domains of c-Raf1 or RalGDS, or direct fusion of MLL to constitutively active K-RAS, H-RAS, or RAP1 was not sufficient for oncogenic activation of MLL. Rather, the AF6 RA1 domain efficiently mediated self-association, suggesting that constitutive MLL self-association is a more common pathogenic mechanism for MLL oncogenesis than indicated by previous studies of rare MLL fusion partners.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395419      PMCID: PMC2904581          DOI: 10.1182/blood-2009-09-243386

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene.

Authors:  Y Gu; T Nakamura; H Alder; R Prasad; O Canaani; G Cimino; C M Croce; E Canaani
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

2.  canoe encodes a novel protein containing a GLGF/DHR motif and functions with Notch and scabrous in common developmental pathways in Drosophila.

Authors:  H Miyamoto; I Nihonmatsu; S Kondo; R Ueda; S Togashi; K Hirata; Y Ikegami; D Yamamoto
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

3.  The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.

Authors:  N Nassar; G Horn; C Herrmann; A Scherer; F McCormick; A Wittinghofer
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

4.  Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation.

Authors:  R Prasad; Y Gu; H Alder; T Nakamura; O Canaani; H Saito; K Huebner; R P Gale; P C Nowell; K Kuriyama
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

5.  PHD--an automatic mail server for protein secondary structure prediction.

Authors:  B Rost; C Sander; R Schneider
Journal:  Comput Appl Biosci       Date:  1994-02

Review 6.  AF-6/cno: neither a kinesin nor a myosin, but a bit of both.

Authors:  C P Ponting
Journal:  Trends Biochem Sci       Date:  1995-07       Impact factor: 13.807

7.  The small oligomerization domain of gephyrin converts MLL to an oncogene.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Blood       Date:  2004-01-29       Impact factor: 22.113

8.  Identification of AF-6 and canoe as putative targets for Ras.

Authors:  M Kuriyama; N Harada; S Kuroda; T Yamamoto; M Nakafuku; A Iwamatsu; D Yamamoto; R Prasad; C Croce; E Canaani; K Kaibuchi
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

9.  A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias.

Authors:  M Djabali; L Selleri; P Parry; M Bower; B D Young; G A Evans
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

10.  Definitive hematopoiesis requires the mixed-lineage leukemia gene.

Authors:  Patricia Ernst; Jill K Fisher; William Avery; Stacey Wade; Daniel Foy; Stanley J Korsmeyer
Journal:  Dev Cell       Date:  2004-03       Impact factor: 12.270

View more
  16 in total

Review 1.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

2.  Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.

Authors:  Ming-Jin Chang; Hongyu Wu; Nicholas J Achille; Mary Rose Reisenauer; Chau-Wen Chou; Nancy J Zeleznik-Le; Charles S Hemenway; Wenzheng Zhang
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 3.  Molecular mechanisms of MLL-associated leukemia.

Authors:  Akihiko Yokoyama
Journal:  Int J Hematol       Date:  2015-03-17       Impact factor: 2.490

4.  Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression.

Authors:  Yi Xu; Renxu Chang; Zhiyong Peng; Yanmei Wang; Weiwei Ji; Jingyu Guo; Lele Song; Cheng Dai; Wei Wei; Yanjun Wu; Xinjian Wan; Chenghao Shao; Lixing Zhan
Journal:  Nat Commun       Date:  2015-05-26       Impact factor: 14.919

5.  [Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia].

Authors:  M X Zhang; W Z Shi; J X Liu; C J Wang; Y Li; W Wang; B Jiang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-10-18

6.  Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell death.

Authors:  Claudia Tregnago; Ambra Da Ros; Elena Porcù; Maddalena Benetton; Manuela Simonato; Luca Simula; Giulia Borella; Katia Polato; Sonia Minuzzo; Giulia Borile; Paola Cogo; Silvia Campello; Alessandro Massi; Romeo Romagnoli; Barbara Buldini; Franco Locatelli; Martina Pigazzi
Journal:  Blood Adv       Date:  2020-09-22

7.  Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.

Authors:  Aniruddha J Deshpande; Liying Chen; Maurizio Fazio; Amit U Sinha; Kathrin M Bernt; Deepti Banka; Stuart Dias; Jenny Chang; Edward J Olhava; Scott R Daigle; Victoria M Richon; Roy M Pollock; Scott A Armstrong
Journal:  Blood       Date:  2013-01-29       Impact factor: 22.113

Review 8.  Recent progress toward epigenetic therapies: the example of mixed lineage leukemia.

Authors:  Tobias Neff; Scott A Armstrong
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

9.  A short splicing isoform of afadin suppresses the cortical axon branching in a dominant-negative manner.

Authors:  Kentaro Umeda; Nariaki Iwasawa; Manabu Negishi; Izumi Oinuma
Journal:  Mol Biol Cell       Date:  2015-03-25       Impact factor: 4.138

10.  Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Authors:  Erica Ballabio; Thomas A Milne
Journal:  Cancers (Basel)       Date:  2012-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.